GEOFFREY F COX Insider Trading $GTCB rEVO Biologics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEOFFREY F COX.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEOFFREY F COX. GEOFFREY F COX is Director in Aviragen Therapeutics, Inc. ($NABI) and Chairman, President and CEO in rEVO Biologics, Inc. ($GTCB) and President, CEO and Chairman in rEVO Biologics, Inc. ($GTCB).
GEOFFREY F COX in rEVO Biologics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEOFFREY F COX: Chairman, President and CEO, President, CEO and Chairman
Holdings: 87,944 shares
Latest Transaction: Nov 04 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GEOFFREY F COX in rEVO Biologics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 1.21 | 31,626 | 38,267 | 87,944 | 56.3 K to 87.9 K (+56.16 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Payment of Exercise | F | 2.66 | 2,331 | 6,200 | 56,318 | 58.6 K to 56.3 K (-3.97 %) |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 0.37 | 110,000 | 40,700 | 110,000 | |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 10,800 | 0 | 586,517 | 575.7 K to 586.5 K (+1.88 %) |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 0.31 | 160,000 | 49,600 | 160,000 | |
| Nov 24 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.15 | 1,500 | 225 | 575,717 | 574.2 K to 575.7 K (+0.26 %) |
| Nov 24 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.16 | 40,900 | 6,544 | 574,217 | 533.3 K to 574.2 K (+7.67 %) |
| Nov 24 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.17 | 43,600 | 7,412 | 533,317 | 489.7 K to 533.3 K (+8.90 %) |
| Jul 03 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 61,200 | 0 | 489,717 | 428.5 K to 489.7 K (+14.28 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.50 | 12,260 | 6,130 | 428,517 | 416.3 K to 428.5 K (+2.95 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.49 | 3,900 | 1,911 | 416,257 | 412.4 K to 416.3 K (+0.95 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.48 | 13,740 | 6,595 | 412,357 | 398.6 K to 412.4 K (+3.45 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.47 | 63,100 | 29,657 | 398,617 | 335.5 K to 398.6 K (+18.81 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.46 | 7,400 | 3,404 | 335,517 | 328.1 K to 335.5 K (+2.26 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 0.63 | 75,000 | 47,250 | 75,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 73,442 | 0 | 328,117 | 254.7 K to 328.1 K (+28.84 %) |
| Jan 08 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.72 | 693 | 501 | 254,675 | 254 K to 254.7 K (+0.27 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.88 | 900 | 792 | 253,982 | 253.1 K to 254 K (+0.36 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.89 | 1,000 | 889 | 253,082 | 252.1 K to 253.1 K (+0.40 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.89 | 7,865 | 7,000 | 252,082 | 244.2 K to 252.1 K (+3.22 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.90 | 1,000 | 900 | 244,217 | 243.2 K to 244.2 K (+0.41 %) |
| Oct 10 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.88 | 1,253 | 1,108 | 243,217 | 242 K to 243.2 K (+0.52 %) |
| Aug 13 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.03 | 6,500 | 6,695 | 241,964 | 235.5 K to 242 K (+2.76 %) |
| Aug 13 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.02 | 7,700 | 7,854 | 235,464 | 227.8 K to 235.5 K (+3.38 %) |
| Jul 10 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.01 | 1,260 | 1,274 | 227,764 | 226.5 K to 227.8 K (+0.56 %) |
| Jun 01 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 1.18 | 22,500 | 26,550 | 22,500 | |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.95 | 1,260 | 1,200 | 226,504 | 225.2 K to 226.5 K (+0.56 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 2,000 | 0 | 225,244 | 227.2 K to 225.2 K (-0.88 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 1,450 | 0 | 2,000 | 550 to 2 K (+263.64 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 1,450 | 0 | 227,244 | 228.7 K to 227.2 K (-0.63 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.99 | 300 | 297 | 228,694 | 228.4 K to 228.7 K (+0.13 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.00 | 7,700 | 7,700 | 228,394 | 220.7 K to 228.4 K (+3.49 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.01 | 16,000 | 16,160 | 220,694 | 204.7 K to 220.7 K (+7.82 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 1.04 | 110,000 | 114,400 | 110,000 | |
| Jan 10 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.94 | 1,260 | 1,189 | 204,694 | 203.4 K to 204.7 K (+0.62 %) |
| Nov 06 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.05 | 4,230 | 4,442 | 203,434 | 199.2 K to 203.4 K (+2.12 %) |
| Nov 06 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.06 | 8,920 | 9,455 | 199,204 | 190.3 K to 199.2 K (+4.69 %) |
| Nov 06 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.07 | 1,150 | 1,231 | 190,284 | 189.1 K to 190.3 K (+0.61 %) |
| Oct 13 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.99 | 1,174 | 1,168 | 189,134 | 188 K to 189.1 K (+0.62 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 1.23 | 1,000 | 1,230 | 187,960 | 187 K to 188 K (+0.53 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.86 | 1,260 | 1,082 | 186,960 | 185.7 K to 187 K (+0.68 %) |
| Apr 11 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.87 | 1,260 | 1,092 | 185,700 | 184.4 K to 185.7 K (+0.68 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 1.03 | 90,000 | 92,700 | 90,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 90,923 | 0 | 184,440 | 93.5 K to 184.4 K (+97.23 %) |
| Jul 07 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.37 | 736 | 1,007 | 92,296 | 91.6 K to 92.3 K (+0.80 %) |
| May 04 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.95 | 3,000 | 2,850 | 91,560 | 88.6 K to 91.6 K (+3.39 %) |
| May 04 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.96 | 2,000 | 1,920 | 88,560 | 86.6 K to 88.6 K (+2.31 %) |
| Apr 11 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.94 | 1,260 | 1,184 | 86,560 | 85.3 K to 86.6 K (+1.48 %) |
| Mar 15 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.80 | 4,200 | 7,560 | 85,300 | 81.1 K to 85.3 K (+5.18 %) |
| Mar 15 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.79 | 1,100 | 1,969 | 81,100 | 80 K to 81.1 K (+1.38 %) |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 1.71 | 75,000 | 128,250 | 75,000 | |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 13,757 | 0 | 80,000 | 66.2 K to 80 K (+20.77 %) |
| Jan 10 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.44 | 692 | 996 | 66,243 | 65.6 K to 66.2 K (+1.06 %) |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Oct 13 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.31 | 741 | 971 | 65,551 | 64.8 K to 65.6 K (+1.14 %) |
| Jul 13 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.70 | 761 | 1,294 | 64,810 | 64 K to 64.8 K (+1.19 %) |
| Apr 12 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 2.20 | 513 | 1,129 | 64,049 | 63.5 K to 64 K (+0.81 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | Chairman, President ... | Grant | A | 2.15 | 1,700 | 3,655 | 63,536 | 61.8 K to 63.5 K (+2.75 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | Chairman, President ... | Grant | A | 2.16 | 600 | 1,296 | 61,836 | 61.2 K to 61.8 K (+0.98 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | Chairman, President ... | Grant | A | 2.15 | 1,700 | 3,655 | 63,536 | 61.8 K to 63.5 K (+2.75 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | Chairman, President ... | Grant | A | 2.16 | 600 | 1,296 | 61,836 | 61.2 K to 61.8 K (+0.98 %) |
| Feb 18 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 3.96 | 75,000 | 297,000 | 75,000 |
Page: 1